Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Oral complications of cancer therapies. Pretherapy interventions to modify salivary dysfunction

Journal Article · · NCI Monographs (National Cancer Institute); (USA)
OSTI ID:6748865
; ; ;  [1]
  1. National Institute of Dental Research, Bethesda, MD (USA)
Salivary gland dysfunction is a common side effect of cancer therapies. Salivary secretions are reduced rapidly after starting head and neck radiotherapy. Salivary gland dysfunction has also been linked to bone marrow transplantation and to cytotoxic chemotherapy. Salivary gland stimulation during radiation has been suggested as a means of reducing radiation damage. Results of an ongoing study investigating the effects of pilocarpine on radiation-induced salivary gland dysfunction suggest that parotid function was preserved, but not submandibular/sublingual function. Also, patients receiving pilocarpine had less frequent oral complaints. Further research is necessary to develop means of preventing or alleviating the salivary side effects of cancer therapies. 37 references.
OSTI ID:
6748865
Journal Information:
NCI Monographs (National Cancer Institute); (USA), Journal Name: NCI Monographs (National Cancer Institute); (USA) Vol. 9; ISSN 0893-2751; ISSN NCIME
Country of Publication:
United States
Language:
English